These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 17912359)
1. Conservation, variability and the modeling of active protein kinases. Knight JD; Qian B; Baker D; Kothary R PLoS One; 2007 Oct; 2(10):e982. PubMed ID: 17912359 [TBL] [Abstract][Full Text] [Related]
2. Recent advances in designing substrate-competitive protein kinase inhibitors. Han KC; Kim SY; Yang EG Curr Pharm Des; 2012; 18(20):2875-82. PubMed ID: 22571656 [TBL] [Abstract][Full Text] [Related]
3. The protein kinase activity modulation sites: mechanisms for cellular regulation - targets for therapeutic intervention. Engh RA; Bossemeyer D Adv Enzyme Regul; 2001; 41():121-49. PubMed ID: 11384741 [No Abstract] [Full Text] [Related]
4. INTEGRATING GENETIC AND STRUCTURAL DATA ON HUMAN PROTEIN KINOME IN NETWORK-BASED MODELING OF KINASE SENSITIVITIES AND RESISTANCE TO TARGETED AND PERSONALIZED ANTICANCER DRUGS. Verkhivker GM Pac Symp Biocomput; 2016; 21():45-56. PubMed ID: 26776172 [TBL] [Abstract][Full Text] [Related]
9. Use of an oriented peptide library to determine the optimal substrates of protein kinases. Songyang Z; Blechner S; Hoagland N; Hoekstra MF; Piwnica-Worms H; Cantley LC Curr Biol; 1994 Nov; 4(11):973-82. PubMed ID: 7874496 [TBL] [Abstract][Full Text] [Related]
10. Exceptional disfavor for proline at the P + 1 position among AGC and CAMK kinases establishes reciprocal specificity between them and the proline-directed kinases. Zhu G; Fujii K; Belkina N; Liu Y; James M; Herrero J; Shaw S J Biol Chem; 2005 Mar; 280(11):10743-8. PubMed ID: 15647260 [TBL] [Abstract][Full Text] [Related]
11. Targeting aurora2 kinase in oncogenesis: a structural bioinformatics approach to target validation and rational drug design. Vankayalapati H; Bearss DJ; Saldanha JW; Muñoz RM; Rojanala S; Von Hoff DD; Mahadevan D Mol Cancer Ther; 2003 Mar; 2(3):283-94. PubMed ID: 12657723 [TBL] [Abstract][Full Text] [Related]
12. Interrogating Regulatory Mechanisms in Signaling Proteins by Allosteric Inhibitors and Activators: A Dynamic View Through the Lens of Residue Interaction Networks. Astl L; Tse A; Verkhivker GM Adv Exp Med Biol; 2019; 1163():187-223. PubMed ID: 31707705 [TBL] [Abstract][Full Text] [Related]
13. Catalytic mechanisms and regulation of protein kinases. Wang Z; Cole PA Methods Enzymol; 2014; 548():1-21. PubMed ID: 25399640 [TBL] [Abstract][Full Text] [Related]
15. KinPred: A unified and sustainable approach for harnessing proteome-level human kinase-substrate predictions. Xue B; Jordan B; Rizvi S; Naegle KM PLoS Comput Biol; 2021 Feb; 17(2):e1008681. PubMed ID: 33556051 [TBL] [Abstract][Full Text] [Related]
16. The evolution of protein kinase inhibitors from antagonists to agonists of cellular signaling. Dar AC; Shokat KM Annu Rev Biochem; 2011; 80():769-95. PubMed ID: 21548788 [TBL] [Abstract][Full Text] [Related]